Picture of GeneDx Holdings logo

WGS — GeneDx Holdings News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMid CapMomentum Trap

Sema4 Holdings Corp expected to post a loss of 21 cents a share - Earnings Preview

* Sema4 Holdings Corp  SMFR.OQ   SMFR.O  is expected to show
a
rise in quarterly revenue when it reports  results on November
14. 
    * The Stamford Connecticut-based  company is expected to
report  a
66.0% increase in revenue to $71.671 million from $43.18 million
a year ago, according to the mean estimate from 4 analysts,
based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Sema4 Holdings Corp
is
for a loss of 21 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Sema4
Holdings
Corp is $3​, above​ its last closing price of $0.94. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Jun. 30 2022  -0.20       -0.21      -0.25     Missed  -19
 Mar. 31 2022  -0.32       -0.31      -0.31     Met     -0.4
 Dec. 31 2021  -0.26       -0.26      -0.17     Beat    34​
 Sep. 30 2021  -0.19       -0.19      -0.43     Missed  -128.7
 ​​                                                     
                                                        ​
 This summary was machine generated November 11 at 17:54 GMT. 
All figures in US dollars  unless otherwise stated

Recent news on GeneDx Holdings

See all news